Total submissions: 22
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
International Society for Gastrointestinal Hereditary Tumours |
RCV000030214 | SCV000106241 | no known pathogenicity | Lynch syndrome | 2013-09-05 | reviewed by expert panel | research | MAF >1% |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000030214 | SCV000052881 | benign | Lynch syndrome | 2011-08-18 | criteria provided, single submitter | clinical testing | Converted during submission to Benign. |
Eurofins Ntd Llc |
RCV000078416 | SCV000110262 | benign | not specified | 2013-01-14 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000078416 | SCV000303145 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Illumina Laboratory Services, |
RCV000616483 | SCV000443337 | benign | Colorectal cancer, hereditary nonpolyposis, type 2 | 2018-03-06 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
Color Diagnostics, |
RCV000449421 | SCV000537353 | benign | Hereditary cancer-predisposing syndrome | 2014-11-26 | criteria provided, single submitter | clinical testing | |
Center for Human Genetics, |
RCV000616483 | SCV000781758 | uncertain significance | Colorectal cancer, hereditary nonpolyposis, type 2 | 2016-11-01 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001650849 | SCV001156601 | benign | not provided | 2023-11-29 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001510183 | SCV001717148 | benign | Hereditary nonpolyposis colorectal neoplasms | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001650849 | SCV001868837 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 28932927, 27629256, 27884173, 15996210, 24689082, 23588873, 16395668) |
Center for Genomic Medicine, |
RCV000078416 | SCV002552493 | benign | not specified | 2023-08-15 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000449421 | SCV002704389 | benign | Hereditary cancer-predisposing syndrome | 2014-11-18 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
KCCC/NGS Laboratory, |
RCV000616483 | SCV004015866 | benign | Colorectal cancer, hereditary nonpolyposis, type 2 | 2023-07-07 | criteria provided, single submitter | clinical testing | |
Pathway Genomics | RCV000144605 | SCV000189932 | benign | Lynch syndrome 1 | 2014-07-24 | no assertion criteria provided | clinical testing | |
Mayo Clinic Laboratories, |
RCV000078416 | SCV000257053 | benign | not specified | no assertion criteria provided | research | ||
Department of Pathology and Laboratory Medicine, |
RCV001354017 | SCV000592408 | benign | Carcinoma of colon | no assertion criteria provided | clinical testing | The c.1558+14G>A variant has been identified in 10 out of 670 proband chromosomes (frequency 0.015) in individuals with colorectal and breast cancer as well as the transitional cell carcinoma of the urinary tract; however no normal population controls were included in these studies (Furihata 2001, Kurzawski 2002, Murata 2002, Palicio 2002, Ward 2002, Lee 2005). It is listed in dbSNP database presented “With non-pathogenic allele” (ID#: rs41562513) with a “global minor allele frequency of 0.054 (1000 genomes), therefore increasing the likelihood that this variant is benign. One study demonstrated by RT-PCR that this variant did not affect splicing (Auclari_2006_16395668), increasing the likelihood this variant does not have clinical significance. This variant is located in the 5' splice region but does not affect the invariant +1 and +2 positions, or positions +3 to +6 that are part of the splicing consensus sequence which sometimes affect splicing. In addition, in-silico or computational prediction software (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer, HumanSpliceFinder) predicts no change in the splice site prediction score. In summary, based on the above information, this variant is classified as benign | |
Diagnostic Laboratory, |
RCV000616483 | SCV000734267 | benign | Colorectal cancer, hereditary nonpolyposis, type 2 | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV000078416 | SCV001798604 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics Laboratory, |
RCV000078416 | SCV001906015 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000078416 | SCV001919830 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000078416 | SCV001956792 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000078416 | SCV001965035 | benign | not specified | no assertion criteria provided | clinical testing |